Cost-Effectiveness Analysis of Stereotactic Ablative Radiation Therapy in Patients With Oligometastatic Cancer
Abhishek Kumar, Christopher Straka, P.T. Courtney, Lucas K. Vitzthum, Paul Riviere, James D. Murphy
Topics & Concepts
SABR volatility modelMedicineAblative caseRadiation therapyQuality-adjusted life yearCost-effectiveness analysisCost effectivenessRandomized controlled trialClinical trialQuality of life (healthcare)Health careOncologyInternal medicineEconomic growthNursingStochastic volatilityFinancial economicsEconomicsVolatility (finance)Risk analysis (engineering)Management of metastatic bone diseaseBrain Metastases and TreatmentLung Cancer Diagnosis and Treatment